Additional file 3 of Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.29288703.v1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 3 of Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer

Figshare
Cancer Immunotherapy and Biomarkers
article

Additional file 3 of Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer

article en

Abstract

No abstract available for this paper.
Figshare
Fudan University (CN), Fudan University Shanghai Cancer Center (CN)
Good health and well-being
Openalex Percentile: Top 42%
Cancer Immunotherapy and Biomarkers
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.